Home LiteratureArticle Details
PMID: 14512553 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.

Journal of virology ·Vol. 77 ·No. 20 ·2003-10-00 ·Pages 11050-9

Padow M, Lai L, Deivanayagam C, DeLucas LJ, Weiss RB, Dunn DM, Wu X, Kappes JC

Abstract

The human immunodeficiency virus type 1 (HIV-1) integrase (IN) protein augments the initiation of reverse transcription. Chimeric HIV-1 containing HIV-2 IN (SG3(IN2)) is severely impaired in virus infectivity and DNA synthesis. To analyze the nature of this defect, we infected T cells with the chimeric SG3(IN2) virus and by continuous passage in cell culture selected for virus with improved replication properties. Viruses from two different time points were chosen for further analysis, an early culture-adapted virus (CF-65) that exhibited an intermediate level of infectivity, and a later-passaged virus (CF-131) that was significantly more infectious. Sequence analysis of multiple clones derived from the CF-65 virus culture demonstrated a diversity of mutations in the reverse transcriptase (RT) and a common V204I IN mutation. Analysis of clones derived from the CF-131 virus indicated the selection of two additional IN mutations, Q96H and K127E, and a fixed V179I RT mutation. By cloning RT and/or IN sequences back into the original SG3(IN2) chimeric virus, we demonstrated that mutations in both RT and IN contributed to the improvement in viral fitness. The effect of the HIV-2IN(IN(2)) mutations on virus DNA synthesis was analyzed by packaging IN(2) mutants into HIV-1 as Vpr-IN(2) fusion proteins. This analysis revealed that the Q96H, K127E and V204I mutations increased the infectivity of the chimeric virus by augmenting the initiation of viral cDNA synthesis in infected cells. The Q96H and K127E mutations are present in adjacent helical structures on the surface of the IN protein and together account for most of the increase observed in DNA synthesis. Our findings provide evidence that the IN protein augments the initiation of reverse transcription through specific interactions with other viral components comprising the initiation complex. Moreover, they implicate specific regions on the surface of IN that may help to elucidate mechanisms by which the HIV-1 IN protein augments the initiation of HIV-1 reverse transcription in vivo.

MeSH Terms
Base Sequence Cell Line Chimera DNA, Viral/analysis,biosynthesis Genetic Complementation Test HIV Integrase/genetics,physiology HIV Reverse Transcriptase/genetics HIV-1/genetics,physiology Humans Mutation Transcription, Genetic Virus Replication
Chemicals
DNA, Viral HIV Integrase HIV Reverse Transcriptase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Padow Marcus
Departments of Microbiology. Medicine. Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Lai Lilin
Deivanayagam Champion
DeLucas Lawrence J
Weiss Robert B
Dunn Diane M
Wu Xiaoyun
Kappes John C
References (39)
39 references, click to expand
  1. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
    J Virol. 2000 May;74(10):4795-806 PMID: 10775618
  2. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
    J Virol. 1998 Apr;72(4):2855-64 PMID: 9525605
  3. Complementation between HIV integrase proteins mutated in different domains.
    EMBO J. 1993 Aug;12(8):3261-7 PMID: 8344263
  4. Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.
    J Virol. 2001 Dec;75(23):11365-72 PMID: 11689617
  5. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    J Virol. 1992 Apr;66(4):2232-9 PMID: 1548759
  6. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  7. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
    J Virol. 1995 Jun;69(6):3389-98 PMID: 7745685
  8. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
    J Virol. 1995 Nov;69(11):6687-96 PMID: 7474078
  9. Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.
    J Virol. 1999 Jan;73(1):453-65 PMID: 9847351
  10. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
    J Virol. 1996 Feb;70(2):721-8 PMID: 8551608
  11. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
    J Virol. 1999 Mar;73(3):2126-35 PMID: 9971795
  12. Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection.
    Cell. 1984 Jul;37(3):1043-52 PMID: 6204767
  13. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other.
    FEBS Lett. 2001 Oct 19;507(1):39-44 PMID: 11682056
  14. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.
    Virology. 1993 Jun;194(2):858-64 PMID: 8503191
  15. Production of trans-lentiviral vector with predictable safety.
    Methods Mol Med. 2003;76:449-65 PMID: 12526179
  16. Ty3 integrase is required for initiation of reverse transcription.
    J Virol. 2002 Mar;76(6):2804-16 PMID: 11861848
  17. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Virology. 1996 May 1;219(1):29-36 PMID: 8623542
  18. Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase.
    J Virol. 1999 May;73(5):4475-80 PMID: 10196350
  19. Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.
    J Virol. 1999 Oct;73(10):8831-6 PMID: 10482639
  20. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
    Nat Med. 2001 Aug;7(8):920-6 PMID: 11479624
  21. Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.
    Biochem J. 2002 Feb 1;361(Pt 3):557-66 PMID: 11802785
  22. Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.
    J Virol. 1990 Oct;64(10):4709-17 PMID: 2204722
  23. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication.
    J Virol. 1996 Jan;70(1):651-7 PMID: 8523588
  24. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    EMBO J. 1997 Aug 15;16(16):5113-22 PMID: 9305652
  25. Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein.
    J Virol. 1991 Apr;65(4):2141-5 PMID: 2002557
  26. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.
    Nucleic Acids Res. 1997 Jul 15;25(14):2745-51 PMID: 9207020
  27. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    J Virol. 2002 May;76(9):4331-40 PMID: 11932399
  28. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
    Cell. 1990 Apr 20;61(2):213-22 PMID: 2331748
  29. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.
    J Virol. 1997 May;71(5):3507-14 PMID: 9094622
  30. Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection.
    J Virol. 1996 Jun;70(6):3870-5 PMID: 8648723
  31. Genetic analysis of the human immunodeficiency virus type 1 integrase protein.
    J Virol. 1994 Mar;68(3):1633-42 PMID: 8107224
  32. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  33. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
    J Virol. 1995 May;69(5):2729-36 PMID: 7535863
  34. Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.
    J Virol. 1986 Oct;60(1):267-74 PMID: 2427747
  35. Analysis of human immunodeficiency virus type 1 integrase mutants.
    Virology. 1995 Aug 1;211(1):332-5 PMID: 7544046
  36. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease.
    J Virol. 1996 Oct;70(10):6820-5 PMID: 8794322
  37. Base-calling of automated sequencer traces using phred. I. Accuracy assessment.
    Genome Res. 1998 Mar;8(3):175-85 PMID: 9521921
  38. Ribbons.
    Methods Enzymol. 1997;277:493-505 PMID: 18488321
  39. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
    Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 PMID: 12019106
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-10-00
Pages
11050-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC224969
Subset
IM
Grants
NIAID NIH HHS · P30 AI027767 · United States
NIAID NIH HHS · AI47714 · United States
NCI NIH HHS · CA73470 · United States
NIAID NIH HHS · R01 AI047714 · United States
NIAID NIH HHS · P30-AI-27767 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com